Gilbert Bensimon, coordonnateur scientifique
Dept Pharmacologie clinique, Centre Hospitalo-Universitaire de la Pitié-Salpêtrière,
47, Bd de l’Hôpital, 75013 Paris, France
Tél : +33 1 42 16 16 69
Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.

P. Nigel Leigh,co- coordonnateur scientifique
Brighton & Sussex Medical School
Trafford Centre for Biomedical Research
University of Sussex, Falmer
East Sussex BN1 9RY
Tél: +44 (0)1273 87 73 57
Fax: +44 (0)1273 87 29 41
Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.

 

Actualités

Rare disease Day 2021 – 28 February 2021

Rare Disease Day takes place on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases such as ALS and their impact on patients' lives.

Take a look at the events happening around the world for rare disease day: https://www.rarediseaseday.org/

Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial

Results in this paper reveal that low dose IL-2 significantly increased the numbers of circulating Tregs, as predicted, and – importantly – improved their ability to control other immune cell responses that contribute to nerve cell damage.

Further information can be found at MND Research Blog

Fin du recrutement de l’essai clinique cet automne

Le recrutement en cours de l’essai clinique de MIROCALS s’arrêtera fin septembre 2019.

Read more
europe

Ce projet est financé par le programme « Horizon 2020 - Instrument PME » de l’Union européenne sous le numéro de subvention 633413.